Engineering antibodies by yeast display
- PMID: 22450168
- DOI: 10.1016/j.abb.2012.03.009
Engineering antibodies by yeast display
Abstract
Since its first application to antibody engineering 15 years ago, yeast display technology has been developed into a highly potent tool for both affinity maturing lead molecules and isolating novel antibodies and antibody-like species. Robust approaches to the creation of diversity, construction of yeast libraries, and library screening or selection have been elaborated, improving the quality of engineered molecules and certainty of success in an antibody engineering campaign and positioning yeast display as one of the premier antibody engineering technologies currently in use. Here, we summarize the history of antibody engineering by yeast surface display, approaches used in its application, and a number of examples highlighting the utility of this method for antibody engineering.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.Protein Eng Des Sel. 2007 Feb;20(2):81-90. doi: 10.1093/protein/gzl057. Epub 2007 Jan 22. Protein Eng Des Sel. 2007. PMID: 17242026
-
Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.Biochem Biophys Res Commun. 2004 Oct 15;323(2):583-91. doi: 10.1016/j.bbrc.2004.08.131. Biochem Biophys Res Commun. 2004. PMID: 15369791
-
Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris.J Biotechnol. 2010 Jan 15;145(2):93-8. doi: 10.1016/j.jbiotec.2009.10.010. Epub 2009 Oct 25. J Biotechnol. 2010. PMID: 19861136
-
The rapid discovery of engineered antibodies.IDrugs. 2007 Aug;10(8):562-5. IDrugs. 2007. PMID: 17665332 Review.
-
Selection of antibodies from synthetic antibody libraries.Arch Biochem Biophys. 2012 Oct 15;526(2):87-98. doi: 10.1016/j.abb.2011.12.028. Epub 2012 Jan 8. Arch Biochem Biophys. 2012. PMID: 22244834 Review.
Cited by
-
Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer.Cancers (Basel). 2020 Sep 30;12(10):2824. doi: 10.3390/cancers12102824. Cancers (Basel). 2020. PMID: 33007970 Free PMC article.
-
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.Front Immunol. 2024 Sep 24;15:1469329. doi: 10.3389/fimmu.2024.1469329. eCollection 2024. Front Immunol. 2024. PMID: 39381002 Free PMC article. Review.
-
Titrating Avidity of Yeast-Displayed Proteins Using a Transcriptional Regulator.ACS Synth Biol. 2023 Feb 17;12(2):419-431. doi: 10.1021/acssynbio.2c00351. Epub 2023 Feb 2. ACS Synth Biol. 2023. PMID: 36728831 Free PMC article.
-
The role of phage display in therapeutic antibody discovery.Int Immunol. 2014 Dec;26(12):649-57. doi: 10.1093/intimm/dxu082. Epub 2014 Aug 18. Int Immunol. 2014. PMID: 25135889 Free PMC article. Review.
-
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.Front Immunol. 2020 Aug 28;11:1986. doi: 10.3389/fimmu.2020.01986. eCollection 2020. Front Immunol. 2020. PMID: 32983137 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources